Letter: a 5‐year long‐term follow‐up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis.
Saved in:
| Title: | Letter: a 5‐year long‐term follow‐up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis. |
|---|---|
| Authors: | Ebel, Friederike1 (AUTHOR), Deterding, Katja2 (AUTHOR), Port, Kerstin1 (AUTHOR), Schlevogt, Bernhard3 (AUTHOR), Manns, Michael P.1,4,5 (AUTHOR), Maasoumy, Benjamin1 (AUTHOR), Cornberg, Markus1 (AUTHOR), Wedemeyer, Heiner2,4,5 (AUTHOR) Wedemeyer.Heiner@mh-hannover.de |
| Source: | Alimentary Pharmacology & Therapeutics. Jan2020, Vol. 51 Issue 1, p194-195. 2p. 1 Graph. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 140415817 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Letter: a 5‐year long‐term follow‐up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ebel%2C+Friederike%22">Ebel, Friederike</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Deterding%2C+Katja%22">Deterding, Katja</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Port%2C+Kerstin%22">Port, Kerstin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schlevogt%2C+Bernhard%22">Schlevogt, Bernhard</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Manns%2C+Michael+P%2E%22">Manns, Michael P.</searchLink><relatesTo>1,4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maasoumy%2C+Benjamin%22">Maasoumy, Benjamin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cornberg%2C+Markus%22">Cornberg, Markus</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wedemeyer%2C+Heiner%22">Wedemeyer, Heiner</searchLink><relatesTo>2,4,5</relatesTo> (AUTHOR)<i> Wedemeyer.Heiner@mh-hannover.de</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Alimentary+Pharmacology+%26+Therapeutics%22">Alimentary Pharmacology & Therapeutics</searchLink>. Jan2020, Vol. 51 Issue 1, p194-195. 2p. 1 Graph. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=140415817 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/apt.15597 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: 194 Titles: – TitleFull: Letter: a 5‐year long‐term follow‐up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ebel, Friederike – PersonEntity: Name: NameFull: Deterding, Katja – PersonEntity: Name: NameFull: Port, Kerstin – PersonEntity: Name: NameFull: Schlevogt, Bernhard – PersonEntity: Name: NameFull: Manns, Michael P. – PersonEntity: Name: NameFull: Maasoumy, Benjamin – PersonEntity: Name: NameFull: Cornberg, Markus – PersonEntity: Name: NameFull: Wedemeyer, Heiner IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2020 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 02692813 Numbering: – Type: volume Value: 51 – Type: issue Value: 1 Titles: – TitleFull: Alimentary Pharmacology & Therapeutics Type: main |
| ResultId | 1 |
